Back to KROS
Nantahala Capital Management, LLC → KROS
Nantahala Capital Management, LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$17M
Q3 2026
Peak value
$17M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $7.3M |
| Q4 2025 | $5.1M |
| Q1 2026 | $15M |
| Q2 2026 | $15.1M |
| Q2 2026 | $15.1M |
| Q3 2026 | $17M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $17M | 1.49M | — | — |
| Q2 2026 | $15.1M | 1.41M | — | — |
| Q2 2026 | $15.1M | 1.41M | — | — |
| Q1 2026 | $15M | 1.36M | — | — |
| Q4 2025 | $5.1M | 250.0K | — | — |
| Q4 2025 | $7.3M | 360.4K | — | — |